LadRx (LADX) 10-K2004 FY Annual report

Filed: 31 Mar 05, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: accidental, Acuity, addressed, adjourned, ailment, Alzheimer, amino, amplification, amplified, amplify, Amylin, arimoclomol, artery, ascribed, asterisk, atrophy, auditor, Bachelor, badly, banker, Barber, begun, Benjamin, bimoclomol, BioMedica, Biorex, boosting, brachial, bring, bulbar, capability, capable, cardiology, Centerpulse, Cephalon, Ceregene, chaperone, chronic, classical, client, College, concur, concurred, concurrent, constant, convened, correctly, counsel, Dacogentm, designee, diabetic, dimensional, disadvantage, discoverer, dismutase, domestic, dysfunction, eighteen, endothelial, error, excellent, expend, external, Februrary, fellowship, fewer, fit, fly, fold, folded, footnote, fullest, fundamental, Guilford, halted, harmful, heading, healing, hearing, heat, hormone, Huntington, hypertensive, Immusol, Imperial, inappropriate, incentivize, indemnify, indirectly, induction, ineffective, ineligibility, ineligible, infarct, infection, infusion, Inin, insignificant, instance, invention, iroxanadine, JJ, jointly, Jolla, KPMG, law, lesser, lethal, Levin, lifespan, linear, literature, macular, mammalian, marketplace, Matthew, mice, minimize, modest, mouse, myocardial, Natalizio, neuropathy, nonexclusive, nonvested, obsolete, offending, opine, Oversight, Panel, Parkinson, physical, physically, Phytopharm, point, prophylactic, proteasome, published, Qualstar, Rana, Reallocation, reconcile, recycling, redemption, refold, Reg, reinstating, repair, repaired, repairing, repay, repurchased, resigned, retinopathy, retrospective, reward, Rilutek, RIP, RT, Salk, Science, shock, shopping, simply, sinking, size, slightly, sooner, spent, Stanford, storage, stressful, subunit, summer, superoxide, Symlin, synthesized, tag, Tariq, threatened, transgenic, travel, ubiquitin, undergone, unforeseen, unpaid, unpredictable, Unproven, unwilling, Viagene, view, withdrawn, wound

Removed: carnahan, distribute, duration, herbert, innovative, mcdade, North, preceding, promise, qualified, raymond, recapitalization, titermax

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

LADX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

CytRx Corporation
Los Angeles, California

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-100947 and 106629) and in the Registration Statements on Form S-8 (Nos. 33-42259, 33-93816, 33-93818, 333-84657, 333-68200, 333-91068, 333-93305 and 333-123339) of our report dated March 11, 2005 relating to the consolidated financial statements and the related financial statement schedule of CytRx Corporation, which appears in this Form 10-K.

/s/ BDO Seidman, LLP

BDO Seidman, LLP
Los Angeles, California

March 30, 2005